16 November 2026Health • Science • Life Emergency number: 112 BG/EN
Treatment in Türkiye

Diagnosis and tests

BRCA and genetic testing for inherited cancer risk: who, how and what results mean

BRCA1 and BRCA2 are genes that help cells repair damaged DNA. A harmful change (mutation) in either gene substantially raises the risk of breast, ovarian and several other cancers. Genetic testing can find these changes, and it works best when it comes with proper genetic counselling.

Author: ZdraveGuide editorial teamPublished: Last reviewed: 6 min read

BRCA and genetic testing for inherited cancer risk: who, how and what results mean

What are BRCA1 and BRCA2?

Everyone carries two copies of BRCA1 and BRCA2, one from each parent. These genes make proteins that mend breaks in DNA. If one copy is inherited with a harmful change, cells are less able to fix errors, and over the years the chance of a cancer developing rises.

Inherited BRCA changes account for only a small share of all breast cancers, but for carriers the risk is much higher than average and cancers often appear at a younger age. The risk of ovarian cancer is also raised, and BRCA2 in particular is linked to prostate cancer, pancreatic cancer and male breast cancer.

Carrying a BRCA variant does not mean you will definitely develop cancer. It means a higher risk – one that can be monitored and reduced.

How BRCA changes are inherited

BRCA variants are passed on in an autosomal dominant way. A carrier, whether a woman or a man, has a 50% chance of passing the variant to each child. Sons and daughters are equally likely to inherit it.

That is why a family history needs to cover both sides of the family. Risk is often passed down through a father who never develops cancer himself, so the pattern can be easy to miss. Breast cancer at a young age, ovarian cancer or breast cancer in a man anywhere in the family is worth raising with a doctor.

Who should consider testing?

Genetic testing is not routine screening for the whole population. Criteria vary between countries, but testing is usually discussed for people with:

  • breast cancer diagnosed at a younger age, or cancer in both breasts;
  • triple-negative breast cancer;
  • ovarian, fallopian tube or primary peritoneal cancer at any age;
  • breast cancer in a man;
  • metastatic prostate cancer or pancreatic cancer;
  • several close relatives with breast, ovarian, pancreatic or prostate cancer;
  • a known BRCA variant in the family;
  • Ashkenazi Jewish ancestry or another background in which certain variants are more common.

If you are unsure whether you qualify, go through your family history with your GP or oncologist and ask about a referral to a clinical genetics service.

What happens during testing

The process starts with genetic counselling. A genetics specialist draws up a family tree, estimates your risk and explains what the test can and cannot tell you and how a result might affect you and your relatives.

The test itself uses a blood or saliva sample. Most laboratories now run a multigene panel that looks at BRCA1 and BRCA2 alongside other cancer-predisposition genes such as PALB2, CHEK2, ATM and the Lynch syndrome genes. Results usually take a few weeks.

If a specific variant has already been found in the family, other relatives can have a targeted test for that variant alone. Where possible, it is most informative to test a relative who has had cancer first.

Sometimes tumour tissue is tested as well. A change found only in the tumour is not necessarily inherited, so these results need careful interpretation by a specialist.

Understanding your result

ResultWhat it meansUsual next step
Positive (pathogenic variant)A harmful change was found; risk is raisedPersonal screening and risk-reduction plan; informing relatives
Negative for a known family variantYou did not inherit the family changeRisk is usually similar to the general population
Negative with no known family variantNo change found in the genes testedScreening based on family history
Variant of uncertain significance (VUS)A change of unclear importanceUsually no change to care; reclassified over time

Variants of uncertain significance are common and most are later shown to be harmless. Surgical decisions should not be based on a VUS alone.

Options if you carry a BRCA variant

A positive result gives you time and choices. Options are discussed individually with an oncologist, gynaecologist and genetics team, taking account of your age, family plans and personal preferences.

Enhanced screening

For women this usually means yearly breast MRI from a younger age, mammograms at the appropriate age and regular review in a breast clinic. Our guide to MRI and CT scans explains how these scans work. There is no reliable screening test for ovarian cancer – ultrasound and CA-125 do not pick it up early enough.

Risk-reducing surgery

Risk-reducing bilateral mastectomy greatly lowers breast cancer risk and can be combined with breast reconstruction. Removing the ovaries and fallopian tubes is usually recommended once a woman has completed her family, at an age that depends on which gene is involved. Because it brings on early menopause, the decision needs careful discussion.

Medication and lifestyle

Some women are offered risk-reducing medication. A healthy weight, less alcohol and regular exercise do not remove genetic risk, but they remain part of sensible cancer prevention.

Men who carry a variant

Men with a BRCA2 variant are advised to be breast aware and to discuss earlier PSA testing with a urologist.

BRCA testing after a cancer diagnosis

When cancer has already been diagnosed, BRCA status can shape treatment. Ovarian, breast, prostate and pancreatic cancers with a BRCA variant often respond to PARP inhibitors, a type of targeted therapy. A result may also influence the extent of breast surgery or a decision to remove the ovaries. For this reason, testing is now often done soon after diagnosis rather than years later.

Emotional, family and privacy issues

A result can bring anxiety, guilt about passing a variant on, or relief. Counselling after the test helps you process what it means. You decide how and when to tell relatives; genetics services can often provide a letter for you to share. Children are not usually tested before adulthood, because no action is needed in childhood.

Genetic information is sensitive personal data. Ask the laboratory how your results are stored and who can access them.

When to see a doctor, and testing abroad

Talk to your GP, gynaecologist or oncologist if several relatives have had breast, ovarian, prostate or pancreatic cancer, if cancer occurred at a young age in your family, or if a BRCA variant is already known. Ask for a referral to genetic counselling. If you notice a new breast lump, unusual bleeding or other symptoms, do not wait for a genetic test – get checked promptly.

Some patients from Bulgaria and elsewhere in Europe have genetic testing, MRI screening or risk-reducing surgery at large accredited hospitals in Istanbul. If you are considering this, check that the laboratory is accredited, that you will receive a written report with counselling in a language you understand, and how follow-up will be arranged at home. New City Clinic in Istanbul coordinates hospital, doctor, accommodation, transfers and an interpreter; medical decisions are made by the doctors. A second medical opinion can also help with big decisions.

Frequently asked questions

If I carry a BRCA variant, will I definitely get cancer?

No. Carrying a variant means a substantially higher risk, not a certainty. Many carriers never develop cancer, and enhanced screening and risk-reducing options lower the risk further.

Should men be tested?

Yes, when there is a reason to test. Men can carry and pass on BRCA variants, and BRCA2 raises their risk of prostate, pancreatic and breast cancer. A father's result is also important information for his children.

How long do results take?

Usually between two and six weeks, depending on the laboratory and the size of the gene panel. A targeted test for a variant already known in the family is often quicker.

What is a variant of uncertain significance?

It is a gene change for which there is not yet enough evidence to say whether it raises cancer risk. Most are eventually reclassified as harmless, so care is guided by family history rather than the variant itself.

Are home DNA tests a good alternative?

Direct-to-consumer tests often check only a handful of known variants and can miss important ones. A negative result from such a test does not rule out inherited risk. Testing arranged through a genetics service is more reliable.

Sources

  1. NCI – BRCA gene changes: cancer risk and genetic testing
  2. NHS – Predictive genetic tests for cancer risk genes
  3. NICE – Familial breast cancer (CG164)
  4. ESMO – Clinical practice guidelines

This article is for education and does not replace consultation, diagnosis or treatment by a doctor. In an emergency call 112.

New City Clinic · Istanbul

Free consultation

Send your enquiry to New City Clinic. We reply in English or Bulgarian, usually within 24 hours.

  • Free consultation and quote
  • Doctor, hospital, hotel, transfer, interpreter
  • Registered with the Turkish Ministry of Health
WhatsApp +39 344 760 1483

Message on WhatsApp